Bioconversion of Milbemycin-related Compounds: Biosynthetic Pathway of Milbemycins

Streptomyces hygroscopicus subsp. aureolacrimosus SANK 60286 and SANK 60576 produce many kinds of milbemycins. Among them, milbemycin α11, α14, A3, and A4 have the most effective acaricidal activity. In this study, we investigated the terminal biosynthetic pathway to milbemycin α14 and A4 which accu...

Full description

Saved in:
Bibliographic Details
Published inJournal of antibiotics Vol. 52; no. 2; pp. 109 - 116
Main Authors NONAKA, KOICHI, KUMASAKA, CHIEKO, OKAMOTO, YOSHIHIRO, MARUYAMA, FUMIO, YOSHIKAWA, HIROJI
Format Journal Article
LanguageEnglish
Published TOKYO JAPAN ANTIBIOTICS RESEARCH ASSOCIATION 1999
JAPAN ANTIBIOT RES ASSN
Japan Antibiotics Research Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Streptomyces hygroscopicus subsp. aureolacrimosus SANK 60286 and SANK 60576 produce many kinds of milbemycins. Among them, milbemycin α11, α14, A3, and A4 have the most effective acaricidal activity. In this study, we investigated the terminal biosynthetic pathway to milbemycin α14 and A4 which accumulated as the final products in these strains. Using cerulenin, a specific inhibitor of fatty acid and polyketide biosynthesis, we conducted bioconversion experiments with cultures of several mutants, including milbemycin A4- and α14-producing strains. The byconversions of milbemycin β6 to milbemycin A4 and milbemycin A4 to milbemycin α14 could be identified. For the biosynthesis of milbemycin A4 from milbemycin β6 in the milbemycin A4-high producing strain, there appeared to be two separate pathways exhibiting different sequences of furan ring formation and C-5 keto reduction steps.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.52.109